Pointe Capital Management’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-89,523
| Closed | -$204K | – | 149 |
|
|
2016
Q2 | $204K | Hold |
89,523
| – | – | 0.15% | 142 |
|
|
2016
Q1 | $225K | Sell |
89,523
-7,520
| -8% | -$18.9K | 0.18% | 126 |
|
|
2015
Q4 | $321K | Hold |
97,043
| – | – | 0.23% | 116 |
|
|
2015
Q3 | $235K | Hold |
97,043
| – | – | 0.14% | 145 |
|
|
2015
Q2 | $284K | Hold |
97,043
| – | – | 0.13% | 143 |
|
|
2015
Q1 | $389K | Buy |
+97,043
| New | +$389K | 0.18% | 102 |
|